2023
DOI: 10.7150/thno.83753
|View full text |Cite
|
Sign up to set email alerts
|

NIR-IIb fluorescence-image guided synergistic surgery/starvation/chemodynamic therapy: an innovative treatment paradigm for malignant non-small cell lung cancers

Abstract: Background: Currently, the prognosis and survival rate for patients bearing non-small cell lung cancer (NSCLC) is still quite poor, mainly due to lack of efficient theranostic paradigms to exert in time diagnostics and therapeutics. Methods: Herein, for NSCLC treatment, we offer a customized theranostic paradigm, termed NIR-IIb fluorescence diagnosis and synergistic surgery/starvation/chemodynamic therapeutics, with a newly designed theranostic nanoplatform PEG/MnCuDCNPs@GOx. The nanoplatform is composed of br… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 59 publications
0
4
0
Order By: Relevance
“…In modern thoracoscopic surgery, reduced tactile feedback may lead to inaccurate nodule localization due to smaller incisions. , New intraoperative imaging techniques are essential to locate lung nodules and ensure R0 resections are performed accurately. With its strong penetration and excellent imaging capabilities, NIR-II fluorescence has demonstrated the specific identification ability for intrapulmonary tumors in previous studies. ,, …”
Section: Introductionmentioning
confidence: 97%
See 1 more Smart Citation
“…In modern thoracoscopic surgery, reduced tactile feedback may lead to inaccurate nodule localization due to smaller incisions. , New intraoperative imaging techniques are essential to locate lung nodules and ensure R0 resections are performed accurately. With its strong penetration and excellent imaging capabilities, NIR-II fluorescence has demonstrated the specific identification ability for intrapulmonary tumors in previous studies. ,, …”
Section: Introductionmentioning
confidence: 97%
“…With its strong penetration and excellent imaging capabilities, NIR-II fluorescence has demonstrated the specific identification ability for intrapulmonary tumors in previous studies. 6,15,16 The combination of MRI and NIR-II imaging is used to meet the current clinical diagnostic and therapeutic needs. For patients with advanced-stage lung cancer, neoadjuvant therapy has gradually become the standard treatment.…”
Section: ■ Introductionmentioning
confidence: 99%
“…This reaction was employed by loading GOx to construct a multifunctional nanoplatform, not only for tumor starvation therapy but also to benefit CDT . A popular approach combines these two factors to construct a nanoplatform as CDT agents, further augmenting the effectiveness of CDT. , For example, Yang and co-workers loaded ultrasmall γ-Fe 2 O 3 nanoparticles and glucose oxidase (GOx) into dendritic mesoporous silica (DMSN) spheres, synthesizing magnetic targeting nanoplatform (γ-Fe 2 O 3 –GOx–DMSN) . In acidic TME, the γ-Fe 2 O 3 nanoparticles could generate • OH from H 2 O 2 , which was produced as a side product of glucose consumption by GOx, through the Fenton reaction.…”
Section: Introductionmentioning
confidence: 99%
“…29–31 The NIR-II DC luminescence falls into the optical transmission window of biological tissues, providing deep tissue penetration and thus improving the temporal and spatial resolution of imaging. 32–34 That is to say, LDNPs with bright NIR-II emission can serve as the ideal fluorescent nanoprobes for optical bioimaging. 35–38…”
Section: Introductionmentioning
confidence: 99%